FyMed Discovery

Discovering medicines with superior clinical outcomes. Transformational technologies that provide a competitive advantage.

2011: Launched CRO services for clinical trial support
FyMed introduced CRO services to enhance R&D capabilities through clinical trial management.

2012: Scientists at FyMed complete devpt of FY10 technology
Results reveal unique NSAID target profiles.

2012: FyMed identifies new anti-inflammatory formulation
Studies show huge potential for new NSAID strategies.

2013: Comparative studies on FyMed NSAID candidates FY101C & FY103B
Results confirm profound clinical efficacy.

2013: Examination of FyMed's technologies in precision medicine
Methods peer reviewed as revolutionary.

2014: Lead FyMed NSAID candidate FY103B
Studies demonstrate superiority over celecoxib and naproxen.

2020: Supported a Phase II trial for a biotech partner
FyMed collaborated with a biotech client to advance discovery research through clinical trials.

While fully independent, FyMed's R&D Division is very integrated into its Clinical Research Division, which supports clinical trial design and execution, translating molecular insights into clinical outcomes. Our technologies enable the identification of unique profiles for a particular disease and reveal the biological pathways it affects. This provides FyMed the additional capability to subclassify patients with different conditions and test these potential new drugs in patients who suffer from specific disease subtypes.
This is an approach that bridges therapeutics and regulatory science, an area of increasing interest and high-priority to the medical community and the FDA. Contact us for clinical research partnerships.

Precision Medicine Drug Target Identification Disease biology guided pre-clinical design platforms Pharmacogenomic, metabolomic, transcriptomic, genetic, & proteomic studies Predictive, pharmaco-dynamic, and prognostic biomarker discovery Identification of molecular signatures Developing breakthrough diagnostics Patient selection / stratification strategies

Targeted Delivery Tissue targeting Systemic targeted delivery Small molecule conjugate delivery Targeting ligands Non-biological targeting platforms

Translational Research Interventional and outcomes assessments Clinical trials and studies Validation of molecular signatures in clinical platforms Clinical efficacy and Comparative effectiveness models Qualitative and Quantitative Analytics CRO services for clinical trial design and execution